Invesco Ltd. - TARSUS PHARMACEUTICALS INC ownership

TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 93 filers reported holding TARSUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of TARSUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$754,766
-1.9%
41,769
-31.7%
0.00%
Q1 2023$769,008
-7.5%
61,178
+7.8%
0.00%
Q4 2022$831,721
+19.5%
56,734
+39.5%
0.00%
Q3 2022$696,000
+11.9%
40,663
-4.6%
0.00%
Q2 2022$622,000
+32.1%
42,617
+52.3%
0.00%
Q1 2022$471,000
-12.5%
27,982
+17.1%
0.00%
Q4 2021$538,000
-12.7%
23,904
-16.5%
0.00%
Q3 2021$616,000
-30.2%
28,614
-6.0%
0.00%
Q2 2021$882,000
-6.5%
30,428
+4.0%
0.00%
Q1 2021$943,000
+17.7%
29,259
+51.1%
0.00%
Q4 2020$801,00019,3670.00%
Other shareholders
TARSUS PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,034,158$25,569,3663.81%
Vivo Capital, LLC 2,262,200$28,435,8541.97%
Frazier Life Sciences Management, L.P. 1,787,527$22,469,2141.63%
Cormorant Asset Management, LP 1,421,422$17,8671.18%
Sands Capital Ventures, LLC 260,000$3,268,2000.81%
RTW INVESTMENTS, LP 2,548,125$32,029,9310.67%
Perceptive Advisors 1,296,416$16,295,9490.48%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,156,032$14,531,3220.32%
Ghost Tree Capital, LLC 80,000$1,006,0000.30%
TimesSquare Capital Management, LLC 1,192,660$14,9920.22%
View complete list of TARSUS PHARMACEUTICALS INC shareholders